tp10
Peptideexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2004 (NCT00082121)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tp10
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02302755 | Phase 1 | Nov 1, 2014 | University of Iowa |
| NCT00082121 | Phase 2 | Apr 1, 2004 | Avant Immunotherapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Avant Immunotherapeutics | For profit | 1 | 1 | 1 | 2004 |
| University of Iowa | Academic/Hospital | 1 | 1 | 1 | 2014 |
2 organizations
Page 1 / 1